Year-End Greeting from the new Director of the WHO Global TB Programme - Dr Tereza Kasaeva
WHO issues a position statement on the use of delamanid for MDR-TB following an expedited review of phase III clinical trial results
WHO leadership meets with TB civil society to strengthen engagement in accelerating the End TB response
WHO Executive Board adopts resolution on upcoming UN General Assembly high-level meeting on TB
UN GENERAL ASSEMBLY HIGH-LEVEL MEETING ON ENDING TB
Special WHO webinar for civil society and partners on the TB guidelines development
Public call for individual patient data on treatment of rifampicin and multidrug-resistant (MDR/RR-TB) tuberculosis
WHO issues new recommendations calling for accelerated uptake of testing and treatment for TB prevention
